CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AstraZeneca Pharmaceuticals LP v. Cobalt Pharmaceuticals Inc.

1:07-cv-00811

Overview

Case Number 1:07-cv-00811
Filing Date 2007-12-11
Status Terminated
Termination Date 2010-07-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Movant

AstraZeneca Pharmaceuticals LP NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Defendant

Cobalt Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Cobalt Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Plaintiff

Shionogi Seiyaku Kabushiki Kaisha Operating Company

Represented By

1 Attorneys Listed

IPR Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

AstraZeneca UK Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 4 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (4 found):
U.S. Courts: 4
U.S. District Court 2013-12-09
2:13-cv-03438

MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP

Asserted Patent
Status: SCD
U.S. District Court 2013-07-31
2:13-cv-02078

MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP

Asserted Patent
Status: SCD
U.S. District Court 2010-10-26
1:10-cv-00915

AstraZeneca UK Limited v. Watson Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2007-12-11
1:07-cv-00808

AstraZeneca Pharmaceuticals LP v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
USRE37314
Pyrimidine derivatives
Filed: 1998-08-27
Issued: 2001-08-07
Expired (Term Ended)
Expires: 2016-01-08
US6316460
Pharmaceutical compositions
Filed: 2000-08-04
Issued: 2001-11-13
Expired (Term Ended)
Expires: 2020-08-04

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

104

Dispositive

71

Granted

3

Denied

1

Pending / Review

79

Motions by Category

Procedural / Extension Motion 13 Motion to Dismiss 20 Claim Construction / Markman Filing 15 Motion to Dismiss (FRCP 12(b)(6)) 2 Motion to Compel Discovery 1 Motion to Strike / Sanctions 4 Motion for Summary Judgment (Rule 56) 49

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER Granting Plaintiffs' Motion For Leave To File A Sur-Reply (see 546 in 08-md1949-JJF); GRANTING Defendants' Motion To Dismiss AstraZeneca Pharmaceuticals, ...
Entry #320 • 2010-06-29 Document →
Motion to Dismiss Pending / Under Review
REDACTED VERSION of (217 in 1:07-cv-00806-JJF, 194 in 1:08-cv-00359-JJF, 330 in 1:07-cv-00810-JJF, 210 in 1:07-cv-00808-JJF, 249 in 1:07-cv-00809-JJF, 262 in 1:...
Entry #285 • 2010-03-04 Document →
Motion to Dismiss Pending / Under Review
REDACTED VERSION of (261 in 1:07-cv-00811-JJF, 193 in 1:08-cv-00359-JJF, 232 in 1:07-cv-00807-JJF, 197 in 1:08-cv-00426-JJF, 248 in 1:07-cv-00809-JJF, 443 in 1:...
Entry #284 • 2010-03-02 Document →
Motion to Dismiss Granted
ORDER Granting 481 STIPULATION TO EXTEND TIME from February 26, 2010 to March 1, 2010 regarding Motion to Dismiss, filed by Aurobindo Pharma Ltd., (Reset Briefi...
Entry #283 • 2010-03-01 Document →
Motion to Dismiss Pending / Under Review
SEALED MEMORANDUM in Opposition re Motion to Dismiss Astrazeneca Pharmaceuticals Lp for Lack of Standing, filed by AstraZeneca Pharmaceuticals LP, AstraZeneca U...
Entry #261 • 2010-02-16 Document →
Motion to Dismiss Pending / Under Review
SEALED DECLARATION re 261 Memorandum in Opposition re Motion to Dismiss Astrazeneca Pharmaceuticals Lp for Lack of Standing, by AstraZeneca Pharmaceuticals LP, ...
Entry #262 • 2010-02-16 Document →

Docket Entries

(379 total)
Pleading / Complaint

COMPLAINT filed against Cobalt Pharmaceuticals Inc., Cobalt Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 149857.) - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuticals Inc., Shionogi Seiyaku Kabushiki Kaisha. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(ead) (Entered: 12/12/2007)

Entry #1 • 2007-12-11
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (ead) (Entered: 12/12/2007)

Entry #2 • 2007-12-11
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE37,314 E; (ead) (Entered: 12/12/2007)

Entry #3 • 2007-12-11
1
Pleading / Complaint

AFFIDAVIT of Service for Summons and Complaint served on Delaware Secretary of State on December 11, 2007, filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuticals Inc., Shionogi Seiyaku Kabushiki Kaisha. (Bourke, Mary) (Entered: 12/12/2007)

Entry #4 • 2007-12-12
1
Pleading / Complaint

SUMMONS Returned Executed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuticals Inc., Shionogi Seiyaku Kabushiki Kaisha. Cobalt Laboratories Inc. served on 12/11/2007, answer due 1/2/2008. (Bourke, Mary) (Entered: 12/12/2007)

Entry #5 • 2007-12-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc